Free Trial
NASDAQ:ELAB

PMGC 5/14/2025 Earnings Report

PMGC logo
$2.30 +0.01 (+0.22%)
As of 10:53 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

PMGC EPS Results

Actual EPS
-$2.90
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

PMGC Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

PMGC Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

PMGC's next earnings date is estimated for Wednesday, August 13, 2025, based on past reporting schedules.

Conference Call Resources

PMGC Earnings Headlines

Head to Head Survey: PMGC (NASDAQ:ELAB) & Alset (NASDAQ:AEI)
Bitcoin just humbled Jeff Bezos
Bitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. While the crowd buys Bitcoin outright, trader Larry Benedict is using a method called “Bitcoin Skimming” to target 6x, 9x, even 22x bigger profits. He reveals how it works in a free video.
See More PMGC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like PMGC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on PMGC and other key companies, straight to your email.

About PMGC

PMGC (NASDAQ:ELAB) (NASDAQ:ELAB) is a global provider of laboratory and diagnostic solutions supporting the life sciences, pharmaceutical research and clinical markets. The company designs, manufactures and distributes a diversified portfolio of instruments, reagents and consumables aimed at accelerating research and improving laboratory efficiency. PMGC’s offerings span from benchtop analyzers to fully integrated automated systems, complemented by data analytics and informatics platforms.

At the core of PMGC’s business are its proprietary technologies for sample preparation, biomolecular assays and high-throughput screening. The company’s reagent lines cover genomic, proteomic and cell-based applications, while its hardware platforms enable precise temperature control, fluorescence detection and real-time monitoring. PMGC also provides a suite of laboratory information management systems (LIMS) and cloud-based software to streamline workflow management and ensure data integrity.

Founded in 1986 and headquartered in Chicago, Illinois, PMGC has developed a global presence with research and manufacturing facilities in North America, Europe and Asia-Pacific. Through a combination of organic growth and strategic acquisitions, the company has expanded its distribution channels to serve academic institutions, pharmaceutical companies and clinical diagnostic labs in over 70 countries. PMGC’s international footprint is supported by a network of regional sales and service teams, as well as partnerships with third-party distributors.

Under the leadership of CEO Dr. Alexandra Langford, PMGC continues to invest in research and development to address emerging trends in precision medicine and personalized diagnostics. The company’s management team brings together expertise in biochemistry, engineering and software development, positioning PMGC to capitalize on growing demand for integrated laboratory solutions. With a focus on innovation and operational excellence, PMGC aims to drive long-term growth by delivering high-value products and services to its global customer base.

View PMGC Profile

More Earnings Resources from MarketBeat